Ainos Inc
Veridion Score
Composite trend over time
Why is AIMD moving today?
Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for AIMD.
AIMD insider activity
Ainos Inc
4 insiders bought in the last 90 days
Net buying: $2.3M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | 2026-06-05 | chiang yao-chung | Insider | buy | $2.05 | 3,500 | 11,279 | $7K | SEC Form 4 |
| 2026-06-05 | 2026-06-03 | chiang yao-chung | Insider | buy | $2.13 | 2,000 | 7,779 | $4K | SEC Form 4 |
| 2026-06-01 | 2026-05-28 | chiang yao-chung | Insider | buy | $2.30 | 250 | 5,779 | $575 | SEC Form 4 |
| 2026-05-29 | 2026-05-27 | chiang yao-chung | Insider | buy | $2.00 | 2,000 | 5,529 | $4K | SEC Form 4 |
| 2026-05-27 | 2026-05-26 | lee ting-chuan | Insider | sell | $1.90 | 109,988 | 807,417 | $209K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 32 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moAIMD contract awards, year to date.
Public federal awards linked to this ticker.
AIMD lobbying filings, year to date.
Registered lobbying filings matched to Ainos Inc.